Product information and disease description
Product description
27 evidence topics · 27 sources
Ulixacaltamide
Essential tremor
- Manufacturer
- Praxis Precision Medicines
- Regulatory submission
- NDA submitted by February 2026
- Launch
- Not announced
- Last updated